1. Home
  2. PULM vs DAIO Comparison

PULM vs DAIO Comparison

Compare PULM & DAIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PULM
  • DAIO
  • Stock Information
  • Founded
  • PULM 2003
  • DAIO 1969
  • Country
  • PULM United States
  • DAIO United States
  • Employees
  • PULM N/A
  • DAIO N/A
  • Industry
  • PULM Biotechnology: Pharmaceutical Preparations
  • DAIO Electrical Products
  • Sector
  • PULM Health Care
  • DAIO Industrials
  • Exchange
  • PULM Nasdaq
  • DAIO Nasdaq
  • Market Cap
  • PULM 20.5M
  • DAIO 22.0M
  • IPO Year
  • PULM N/A
  • DAIO N/A
  • Fundamental
  • Price
  • PULM $4.87
  • DAIO $3.21
  • Analyst Decision
  • PULM
  • DAIO Strong Buy
  • Analyst Count
  • PULM 0
  • DAIO 1
  • Target Price
  • PULM N/A
  • DAIO $5.22
  • AVG Volume (30 Days)
  • PULM 11.0K
  • DAIO 43.4K
  • Earning Date
  • PULM 08-06-2025
  • DAIO 10-23-2025
  • Dividend Yield
  • PULM N/A
  • DAIO N/A
  • EPS Growth
  • PULM N/A
  • DAIO N/A
  • EPS
  • PULM N/A
  • DAIO N/A
  • Revenue
  • PULM $369,000.00
  • DAIO $22,732,000.00
  • Revenue This Year
  • PULM N/A
  • DAIO $9.52
  • Revenue Next Year
  • PULM $134.88
  • DAIO $5.84
  • P/E Ratio
  • PULM N/A
  • DAIO N/A
  • Revenue Growth
  • PULM N/A
  • DAIO N/A
  • 52 Week Low
  • PULM $1.78
  • DAIO $1.88
  • 52 Week High
  • PULM $10.40
  • DAIO $3.48
  • Technical
  • Relative Strength Index (RSI)
  • PULM 44.33
  • DAIO 52.95
  • Support Level
  • PULM $4.65
  • DAIO $3.01
  • Resistance Level
  • PULM $5.00
  • DAIO $3.27
  • Average True Range (ATR)
  • PULM 0.16
  • DAIO 0.17
  • MACD
  • PULM 0.06
  • DAIO -0.00
  • Stochastic Oscillator
  • PULM 76.92
  • DAIO 78.38

About PULM Pulmatrix Inc.

Pulmatrix Inc is a biopharmaceutical company that has focused on the development of novel inhaled therapeutic products intended to prevent and treat migraine and respiratory diseases with important unmet medical needs using its patented dry powder delivery technology, iSPERSE. Its pipeline of clinical assets includes PUR3100 for the treatment of acute migraine, PUR1800 for the treatment of acute exacerbations of chronic obstructive pulmonary disease (AECOPD), and PUR1900 for the treatment of ABPA in patients with asthma and in patients with cystic fibrosis (CF).

About DAIO Data I/O Corporation

Data I/O Corp is a provider of programming, security deployment, security provisioning, and associated Intellectual Property protection and management solutions used in electronics manufacturing with flash memory, microcontrollers, and flash memory-based intelligent devices as well as secure element devices, authentication devices, and secure microcontrollers. It is engaged in focused on the design, manufacturing and sale of programming systems used by designers and manufacturers of electronic products. It has its geographic presence in the United States, Europe, and Asia and others. The company derives the majority of its revenue from Asia and others.

Share on Social Networks: